Drug Education Guide

Ipilimumab (Patient)

CTLA-4 inhibitor Immunotherapy Monoclonal antibody

Ipilimumab (Patient)

CTLA-4 inhibitor Immunotherapy Monoclonal antibody
Light Sensitive Fall Risk
Medication Basics

Drug Name

Ipilimumab (Brand names: Yervoy®)

Purpose / Indication

Used to treat certain cancers such as melanoma, renal cell carcinoma, colorectal cancer, lung cancer, mesothelioma, and other indications, often in combination with nivolumab.

Dosage & Administration

Dose Schedule

Given as an intravenous infusion on a protocol-specific schedule. It may be given alone or in combination with nivolumab depending on diagnosis and treatment plan.

Route

IV (Intravenous)

Timing Considerations

Treatment is given in cycles. The infusion schedule is determined by the oncology team and may change if side effects occur.

Time of Day

Flexible

Special Instructions

Keep all appointments and tell your care team about new symptoms before each treatment.

Injection Techniques

This medicine is given by trained healthcare professionals through an IV line.

Mechanism of Action

Mechanism

This medicine activates the immune system so it can better attack cancer cells. Because it strengthens immune activity, it can also cause inflammation in normal organs.

13 More Sections — Members Only

Free membership unlocks the complete guide.

  • Side Effects
  • Drug Interactions
  • Contraindications
  • Monitoring
  • Adherence
  • + 8 more…
Was this guide helpful?